Key Highlights
- Nebius Group (NBIS) climbed 11.8% to close at $154.49 on Friday, reaching an intraday peak of $156.00
- The firm announced plans to purchase Eigen AI for approximately $643 million through a combination of cash and equity
- The acquisition is designed to strengthen Nebius’ AI inference capabilities and broaden its footprint in California’s Bay Area
- Wall Street analysts maintain an average “Moderate Buy” rating with a consensus target of $154.75
- First-quarter 2026 financial results are slated for release on May 13, before market open
Shares of Nebius Group (NBIS) surged 11.8% during Friday’s session, peaking at $156.00 before closing at $154.49. Trading volume reached approximately 15.7 million shares, modestly exceeding typical daily activity.
The rally was triggered by news that the company struck an agreement to purchase Eigen AI for roughly $643 million in a transaction combining cash and shares.
Eigen AI specializes in inference technology and post-training optimization solutions. Nebius intends to integrate these features into its Nebius Token Factory platform, which handles production-scale AI workflows.
The transaction is anticipated to finalize within weeks, subject to customary closing requirements including regulatory approvals.
Nebius indicated the acquisition will also strengthen its presence in the United States. The founding engineers from Eigen AI are expected to establish an engineering and research hub in the San Francisco Bay Area.
The stock received additional momentum from heightened options trading. Market participants purchased approximately 130,000 call contracts during the session — roughly 23% higher than typical levels — indicating speculative positioning around upcoming events.
A widespread technology sector rally also provided support. AI-focused and cloud computing stocks posted gains Friday as the Nasdaq advanced.
Wall Street Perspectives
Analyst opinions on NBIS are generally favorable, though not unanimous. The consensus rating stands at “Moderate Buy” with an average price objective of $154.75, closely aligned with Friday’s closing price.
DA Davidson leads with the most optimistic forecast at $200.00, whereas Morgan Stanley maintains a more conservative stance with an “equal weight” recommendation and a $126.00 price target. Bank of America and Compass Point both carry “buy” ratings with $150.00 targets.
Executive Trading and Financial Metrics
Regarding insider transactions, two company leaders divested shares in mid-April. Director Elena Bunina disposed of 6,250 shares at $161.22 per share, while CRO Marc Boroditsky sold 4,500 shares at $160.10. Both transactions occurred under previously established 10b5-1 trading arrangements.
Cumulatively, company insiders offloaded approximately 129,740 shares valued at more than $14.6 million over the past three months.
The company’s financial performance continues to raise questions. Nebius fell short of earnings expectations in its most recent quarterly report, recording a loss of $0.69 per share versus the consensus estimate of -$0.42. Revenue totaled $227.7 million, missing the anticipated $246 million.
The company currently trades at a P/E ratio of -105.82 and carries a beta of 4.20, indicating substantial volatility and elevated risk characteristics. Analysts project a full-year loss of $2.44 per share.
The stock’s 50-day moving average stands at $120.73, with its 200-day average at $106.24, placing Friday’s close significantly above both technical benchmarks.
Institutional shareholders control approximately 21.9% of outstanding NBIS shares.
First-quarter 2026 earnings are scheduled for May 13, before the opening bell.
